253 related articles for article (PubMed ID: 31127314)
1. Soluble receptor for AGE in diabetic nephropathy and its progression in Finnish individuals with type 1 diabetes.
Wadén JM; Dahlström EH; Elonen N; Thorn LM; Wadén J; Sandholm N; Forsblom C; Groop PH;
Diabetologia; 2019 Jul; 62(7):1268-1274. PubMed ID: 31127314
[TBL] [Abstract][Full Text] [Related]
2. Association of the receptor for advanced glycation end products (RAGE) -374 T/A gene polymorphism and circulating soluble RAGE with nephropathy in type 1 diabetic patients.
Abdel-Azeez HA; El-Okely AM
Egypt J Immunol; 2009; 16(1):95-106. PubMed ID: 20726326
[TBL] [Abstract][Full Text] [Related]
3. Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes.
Thomas MC; Söderlund J; Lehto M; Mäkinen VP; Moran JL; Cooper ME; Forsblom C; Groop PH;
Diabetologia; 2011 Oct; 54(10):2669-77. PubMed ID: 21607631
[TBL] [Abstract][Full Text] [Related]
4. Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes.
Saraheimo M; Forsblom C; Thorn L; Wadén J; Rosengård-Bärlund M; Heikkilä O; Hietala K; Gordin D; Frystyk J; Flyvbjerg A; Groop PH;
Diabetes Care; 2008 Jun; 31(6):1165-9. PubMed ID: 18346990
[TBL] [Abstract][Full Text] [Related]
5. Relationship between levels of advanced glycation end products and their soluble receptor and adverse outcomes in adults with type 2 diabetes.
Thomas MC; Woodward M; Neal B; Li Q; Pickering R; Marre M; Williams B; Perkovic V; Cooper ME; Zoungas S; Chalmers J; Hillis GS;
Diabetes Care; 2015 Oct; 38(10):1891-7. PubMed ID: 26253728
[TBL] [Abstract][Full Text] [Related]
6. Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes.
Tan KC; Shiu SW; Chow WS; Leng L; Bucala R; Betteridge DJ
Diabetologia; 2006 Nov; 49(11):2756-62. PubMed ID: 16969649
[TBL] [Abstract][Full Text] [Related]
7. Genetic variants in the receptor for advanced glycation end products (RAGE) gene were associated with circulating soluble RAGE level but not with renal function among Asians with type 2 diabetes: a genome-wide association study.
Lim SC; Dorajoo R; Zhang X; Wang L; Ang SF; Tan CSH; Yeoh LY; Ng XW; Li N; Su C; Liu S; Wong MDS; Low KMS; Yao AO; Babitha J; Fun S; Zhou S; Lee SBM; Tang WE; Tavintharan S; Sum CF; Liu JJ
Nephrol Dial Transplant; 2017 Oct; 32(10):1697-1704. PubMed ID: 27448675
[TBL] [Abstract][Full Text] [Related]
8. Decline in estimated glomerular filtration rate is associated with risk of end-stage renal disease in type 2 diabetes with macroalbuminuria: an observational study from JDNCS.
Shimizu M; Furuichi K; Toyama T; Funamoto T; Kitajima S; Hara A; Ogawa D; Koya D; Ikeda K; Koshino Y; Kurokawa Y; Abe H; Mori K; Nakayama M; Konishi Y; Samejima KI; Matsui M; Yamauchi H; Gohda T; Fukami K; Nagata D; Yamazaki H; Yuzawa Y; Suzuki Y; Fujimoto S; Maruyama S; Kato S; Naito T; Yoshimura K; Yokoyama H; Wada T;
Clin Exp Nephrol; 2018 Apr; 22(2):377-387. PubMed ID: 28889347
[TBL] [Abstract][Full Text] [Related]
9. Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy.
Skupien J; Smiles AM; Valo E; Ahluwalia TS; Gyorgy B; Sandholm N; Croall S; Lajer M; McDonnell K; Forsblom C; Harjutsalo V; Marre M; Galecki AT; Tregouet DA; Wu CY; Mychaleckyj JC; Nickerson H; Pragnell M; Rich SS; Pezzolesi MG; Hadjadj S; Rossing P; Groop PH; Krolewski AS
Diabetes Care; 2019 Jan; 42(1):93-101. PubMed ID: 30455333
[TBL] [Abstract][Full Text] [Related]
10. Smoking and progression of diabetic nephropathy in patients with type 1 diabetes.
Feodoroff M; Harjutsalo V; Forsblom C; Thorn L; Wadén J; Tolonen N; Lithovius R; Groop PH
Acta Diabetol; 2016 Aug; 53(4):525-33. PubMed ID: 26668013
[TBL] [Abstract][Full Text] [Related]
11. Higher plasma soluble Receptor for Advanced Glycation End Products (sRAGE) levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study.
Nin JW; Jorsal A; Ferreira I; Schalkwijk CG; Prins MH; Parving HH; Tarnow L; Rossing P; Stehouwer CD
Diabetes; 2010 Aug; 59(8):2027-32. PubMed ID: 20522598
[TBL] [Abstract][Full Text] [Related]
12. Regression of albuminuria and its association with incident cardiovascular outcomes and mortality in type 1 diabetes: the FinnDiane Study.
Jansson FJ; Forsblom C; Harjutsalo V; Thorn LM; Wadén J; Elonen N; Ahola AJ; Saraheimo M; Groop PH;
Diabetologia; 2018 May; 61(5):1203-1211. PubMed ID: 29423580
[TBL] [Abstract][Full Text] [Related]
13. Plasma sRAGE is not associated with urinary microalbumin excretion in type 2 diabetic nephropathy at the early stage.
Yu JY; An XF; Liu JS; Ten SC; Wang X; Zhao Y; Huang S; Gu WJ; Gao F
Diabetes Res Clin Pract; 2010 Feb; 87(2):157-60. PubMed ID: 19945761
[TBL] [Abstract][Full Text] [Related]
14. Sphingomyelin and progression of renal and coronary heart disease in individuals with type 1 diabetes.
Pongrac Barlovic D; Harjutsalo V; Sandholm N; Forsblom C; Groop PH;
Diabetologia; 2020 Sep; 63(9):1847-1856. PubMed ID: 32564139
[TBL] [Abstract][Full Text] [Related]
15. Urinary adiponectin is an independent predictor of progression to end-stage renal disease in patients with type 1 diabetes and diabetic nephropathy.
Panduru NM; Saraheimo M; Forsblom C; Thorn LM; Gordin D; Wadén J; Tolonen N; Bierhaus A; Humpert PM; Groop PH;
Diabetes Care; 2015 May; 38(5):883-90. PubMed ID: 25720601
[TBL] [Abstract][Full Text] [Related]
16. The serum uric acid concentration is not causally linked to diabetic nephropathy in type 1 diabetes.
Ahola AJ; Sandholm N; Forsblom C; Harjutsalo V; Dahlström E; Groop PH;
Kidney Int; 2017 May; 91(5):1178-1185. PubMed ID: 28238338
[TBL] [Abstract][Full Text] [Related]
17. Association between mannose-binding lectin, high-sensitivity C-reactive protein and the progression of diabetic nephropathy in type 1 diabetes.
Hansen TK; Forsblom C; Saraheimo M; Thorn L; Wadén J; Høyem P; Østergaard J; Flyvbjerg A; Groop PH;
Diabetologia; 2010 Jul; 53(7):1517-24. PubMed ID: 20396997
[TBL] [Abstract][Full Text] [Related]
18. Effects of atorvastatin on progression of diabetic nephropathy and local RAGE and soluble RAGE expressions in rats.
Lu L; Peng WH; Wang W; Wang LJ; Chen QJ; Shen WF
J Zhejiang Univ Sci B; 2011 Aug; 12(8):652-9. PubMed ID: 21796806
[TBL] [Abstract][Full Text] [Related]
19. Soluble RAGE, diabetic nephropathy and genetic variability in the AGER gene.
Kanková K; Kalousová M; Hertlová M; Krusová D; Olsovský J; Zima T
Arch Physiol Biochem; 2008 Apr; 114(2):111-9. PubMed ID: 18615900
[TBL] [Abstract][Full Text] [Related]
20. Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling.
Hou B; Qiang G; Zhao Y; Yang X; Chen X; Yan Y; Wang X; Liu C; Zhang L; Du G
Cell Physiol Biochem; 2017; 44(6):2378-2394. PubMed ID: 29262395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
